Page 95 - Sohini Das

How Covid-19 gave a push to domestic med tech manufacturing industry

From PPEs to ventilators to face shields, manufacturers have invested money to ramp up production and deliver during this crisis

PPEs, work-life balance the new normal as pharma salesforce hits the field

GSK leads the charge with staggered return-to-work, others plans yoga sessions and health care webinars for salesperson's family

Covid-19 impact: Indian firms look to fill in for US' Famotidine crunch

Some see this as an opportunity for Indian firms like Alembic, Aurobindo who make both the bulk drug and the formulation

Lockdown 3.0: Pharma hubs take extra precaution to tame Covid-19 outbreak

Recently, while 26 workers at Cadila Pharmaceuticals facility in Ahmedabad tested positive for Covid-19, one person at Sun Pharma's Halol plant tested positive.

Govt in talks with industry on production of Gilead's remdesivir for trials

Checks with industry on when can production begin here for trials

Govt allows import of superior testing technologies in Covid-19 battle

Players like Abbott, Roche, Trivitron, Eris get approvals to import chemiluminescent kits, ELISA kits too get nod

Govt assures medical equipment supplies as Covid cases cross 35,000

Seven firms to ramp up manufacturing to meet June ventilator target of 75,000 units; order for oxygen supplies made to local companies

In race to stop Covid-19, Indian drugmakers to conduct clinical trials

Glenmark, Zydus Cadila to start trials in May

Chemists not to sell cold, flu medicines without valid prescriptions

Around five states asked medical shops to keep a record of patients who buy medicines for fever, cough and cold

Covid-19 spread: Makers of RT-PCR kits boost production as rapid tests fail

With imports getting stringent, indigenous players like MyLab and CoSara Diagnostics are seeing a rise in enquiries from state and Central govts and private laboratories alike

MyLab starts making RNA extraction kits for crucial Covid-19 test

There is a huge shortage in India of these kits, which are critical in extracting sufficient quantities of RNA for accurate molecular diagnosis

Covid-19 lockdown: Domestic pharma growth takes hit as stock piles up

Inventory days have gone up from 31 days as on March 22 to 41 days as on April 22

Coronavirus outbreak: India cancels Chinese rapid antibody test kit orders

ICMR cancels Wondfo's test kits; row on prices and efficacy erupts

India to test 100-yr-old vaccine on adults as war on Covid-19 hots up

The 100-yr old vaccine has an established safety profile; if effective, it can hit the market within this year

Lockdown hits production of anti-TB drugs, health min seeks to ban export

In a letter to various departments, the health ministry has said the "situation calls for extraordinary measures" to make sure that TB patients do not face challenges in diagnosis or treatment.

ICMR begins trials on Covid-19 patients to test plasma therapy's efficacy

Plan is to have 20-25 such trials across India under the apex health research institute

Mumbai ramps up testing to three-fold to 4,000 samples a day

Starts door-to-door screening in Worli and Dharavi; 81% tested in Maharashtra are asymptomatic; BMC awaits rapid antibody test kits; isolation centres, Covid-19 beds being added rapidly

Cadila Healthcare at the forefront, looks at biologic drug to treat Covid

Company is already working on developing 2 vaccine candidates, diagnostic kits and also making HCQ

How Mumbai admin is battling coronavirus as cases continue to spike

The city administration is trying to ramp up the isolation and treatment center capacities here as cases continue to spike

Indian pharma majors step in to develop, import coronavirus test kits

The rapid test uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein